Source briefingAugust 25, 2026Health & Science
Frequency and prognostic outcomes of emergency diagnosis in 13 non-neoplastic conditions in England: A population-based cohort study using linked electronic health records of 1.7 million patients

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.
What the source reports
by Emma Whitfield, Becky White, Matthew E. Barclay, Meena Rafiq, Nadine Zakkak, Marta Berglund, Hardeep Singh, Sean McPhail, Spiros Denaxas, Georgios Lyratzopoulos Background In patients with cancer, diagnosis through or soon after the use of emergency hospital care (‘emergency diagnosis’) is associated with advanced disease and poor prognosis.
The varied and complex reasons for emergency diagnoses—including rapid disease progression, patient factors, and system delays—are unlikely to be unique to cancer. However, little is known about the frequency and prognostic outcomes of emergency…
Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.
Source & verification
Primary source: PLOS Medicine · August 25, 2026
FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.
Continue reading

US Tries but Fails to Dilute UN Human Rights Resolutions
US Attempts to Weaken UN Human Rights Resolutions: An Evidence Review What is established In late 2026, during sessions of the United Nations General…

Medical device makers have gotten worse at disclosing when their products harm people, new study finds. The FDA let them.
What is established A recent peer-reviewed study published in The BMJ and reported by the International Consortium of Investigative Journalists (ICIJ) reveals a decline…

EMA/PE/0000181364
What is established The European Medicines Agency (EMA) has granted a decision regarding a paediatric investigation plan (PIP) for vosoritide as of 8 August…